|
1
|
Locksley RM, Killeen N and Lenardo MJ: The
TNF and TNF receptor superfamilies: Integrating mammalian biology.
Cell. 104:487–501. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Idriss HT and Naismith JH: TNF alpha and
the TNF receptor superfamily: Structure-function relationship(s).
Microsc Res Tech. 50:184–195. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Palladino MA Jr, Patton JS, Figari IS and
Shalaby MR: Possible relationships between in vivo antitumour
activity and toxicity of tumour necrosis factor-alpha. Ciba Found
Symp. 131:21–38. 1987.PubMed/NCBI
|
|
4
|
Asher A, Mulé JJ, Reichert CM, Shiloni E
and Rosenberg SA: Studies on the anti-tumor efficacy of
systemically administered recombinant tumor necrosis factor against
several murine tumors in vivo. J Immunol. 138:963–974.
1987.PubMed/NCBI
|
|
5
|
Rice TW, Wheeler AP, Morris PE, Paz HL,
Russell JA, Edens TR and Bernard GR: Safety and efficacy of
affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for
injection (CytoFab) in severe sepsis. Crit Care Med. 34:2271–2281.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qiu P, Cui X, Barochia A, Li Y, Natanson C
and Eichacker PQ: The evolving experience with therapeutic TNF
inhibition in sepsis: Considering the potential influence of risk
of death. Expert Opin Investig Drugs. 20:1555–1564. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang C, Niu J, Li M, Teng Y, Wang H and
Zhang Y: Tumor vasculature-targeted recombinant mutated human TNF-α
enhanced the antitumor activity of doxorubicin by increasing tumor
vessel permeability in mouse xenograft models. PLoS One.
9:e870362014. View Article : Google Scholar
|
|
8
|
John A and Tuszynski G: The role of matrix
metalloproteinases in tumor angiogenesis and tumor metastasis.
Pathol Oncol Res. 7:14–23. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ryzhakova OS and Solov’eva NI: Matrix
metalloproteinases (MMP) - MMP-1, -2, -9 and its endogenous
activity regulators in transformed by E7 oncogene HPV16 and HPV18
cervical carcinoma cell lines. Biomed Khim. 59:530–540. 2013.In
Russian. View Article : Google Scholar
|
|
10
|
Decock J, Thirkettle S, Wagstaff L and
Edwards DR: Matrix metalloproteinases: Protective roles in cancer.
J Cell Mol Med. 15:1254–1265. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Overall CM and Kleifeld O: Tumour
microenvironment - opinion: Validating matrix metalloproteinases as
drug targets and anti-targets for cancer therapy. Nat Rev Cancer.
6:227–239. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Said AH, Raufman JP and Xie G: The role of
matrix metalloproteinases in colorectal cancer. Cancers (Basel).
6:366–375. 2014. View Article : Google Scholar
|
|
13
|
Spinale FG and Villarreal F: Targeting
matrix metalloproteinases in heart disease: Lessons from endogenous
inhibitors. Biochem Pharmacol. 90:7–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meier S, Güthe S, Kiefhaber T and Grzesiek
S: Foldon, the natural trimerization domain of T4 fibritin,
dissociates into a monomeric A-state form containing a stable
beta-hairpin: Atomic details of trimer dissociation and local
beta-hairpin stability from residual dipolar couplings. J Mol Biol.
344:1051–1069. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Q, Hou G, Huang D and Chen S:
Construction and expression of hTNF-alpha fusion protein mediated
by MMP1. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 28:534–537. 2011.In
Chinese. PubMed/NCBI
|
|
16
|
Soma G, Kitahara N, Tsuji Y, et al:
Improve of cytotoxicity of tumor necrosis factor (TNF) by increase
in basicity of its N-terminal region. Biochem Biophys Res Commun.
148:629–635. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baeyens KD, De Bondt HL, Raeymaekers A,
Fiers W and De Ranter CJ: The structure of mouse tumournecrosis
factor at 1.4 A resolution: Towards modulation of its selectivity
and trimerization. Acta Crsyrallogr D Biol Crystallogr. 55:772–778.
1999. View Article : Google Scholar
|
|
18
|
Kasibhatla S, Amarante-Mendes GP, Finucane
D, Brunner T, Bossy-Wetzel E and Green DR: Staining of suspension
cells with hoechst 33258 to detect apoptosis. CSH Protoc. 2006:pii:
pdb. prot44922006.
|
|
19
|
Zhang Y, Hong H and Cai W: Tumor-targeted
drug delivery with aptamers. Curr Med Chem. 18:4185–4194. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Graf N and Lippard SJ: Redox activation of
metal-based prodrugs as a strategy for drug delivery. Adv Drug
Deliv Rev. 64:993–1004. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Awad AE, Kandalam V, Chakrabarti S, Wang
X, Penninger JM, Davidge ST, Oudit GY and Kassiri Z: Tumor necrosis
factor induces matrix metalloproteinases in cardiomyocytes and
cardiofibroblasts differentially via superoxide production in a
PI3Kgamma-dependent manner. Am J Physiol Cell Physiol.
298:C679–C692. 2010. View Article : Google Scholar
|
|
22
|
Torbati E, Ghassab RK and Davachi ND:
Recombinant HCV core protein and the secretion of associated
cytokines (IL-6, TNF-α and IFN-γ) in immunized mice. Pak J Biol
Sci. 16:2041–2045. 2013. View Article : Google Scholar
|
|
23
|
Roy R, Yang J and Moses MA: Matrix
metalloproteinases as novel biomarkers and potential therapeutic
targets in human cancer. J Clin Oncol. 27:5287–5297. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Douni E, Rinotas V, Makrinou E, et al: A
RANKL G278R mutation causing osteopetrosis identifies a functional
amino acid essential for trimer assembly in RANKL and TNF. Hum Mol
Genet. 21:784–798. 2012. View Article : Google Scholar
|
|
25
|
Zhang C, Liu Y, Zhao D, Li X, Yu R and Su
Z: Facile purification of Escherichia coli expressed tag-free
recombinant human tumor necrosis factor alpha from supernatant.
Protein Expr Purif. 95:195–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Waugh DS: Making the most of affinity
tags. Trends Biotechnol. 23:316–320. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vinckier NK, Chworos A and Parsons SM:
Improved isolation of proteins tagged with glutathione
S-transferase. Protein Expr Purif. 75:161–164. 2011. View Article : Google Scholar
|
|
28
|
Ben Nasr H, Chahed K, Remadi S, Zakhama A
and Chouchane L: Expression and clinical significance of latent
membrane protein-1, matrix metalloproteinase-1 and Ets-1
transcription factor in tunisian nasopharyngeal carcinoma patients.
Arch Med Res. 40:196–203. 2009. View Article : Google Scholar : PubMed/NCBI
|
